Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005681 | spliceosomal complex | 3 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0071013 | catalytic step 2 spliceosome | 3 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A0A3Q8IPW3
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0018193 | peptidyl-amino acid modification | 5 | 12 |
GO:0018208 | peptidyl-proline modification | 6 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:0006457 | protein folding | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0016853 | isomerase activity | 2 | 12 |
GO:0016859 | cis-trans isomerase activity | 3 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 81 | 85 | PF00656 | 0.355 |
CLV_NRD_NRD_1 | 101 | 103 | PF00675 | 0.210 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.210 |
DOC_MAPK_gen_1 | 227 | 235 | PF00069 | 0.349 |
DOC_MAPK_MEF2A_6 | 44 | 51 | PF00069 | 0.387 |
DOC_USP7_MATH_1 | 142 | 146 | PF00917 | 0.285 |
DOC_USP7_MATH_1 | 182 | 186 | PF00917 | 0.543 |
DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.361 |
DOC_USP7_MATH_1 | 85 | 89 | PF00917 | 0.425 |
DOC_USP7_UBL2_3 | 215 | 219 | PF12436 | 0.608 |
DOC_WW_Pin1_4 | 138 | 143 | PF00397 | 0.409 |
LIG_14-3-3_CanoR_1 | 117 | 123 | PF00244 | 0.269 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.253 |
LIG_BIR_III_4 | 192 | 196 | PF00653 | 0.558 |
LIG_BRCT_BRCA1_1 | 133 | 137 | PF00533 | 0.269 |
LIG_BRCT_BRCA1_1 | 24 | 28 | PF00533 | 0.361 |
LIG_EH_1 | 237 | 241 | PF12763 | 0.398 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.340 |
LIG_FHA_2 | 125 | 131 | PF00498 | 0.308 |
LIG_FHA_2 | 205 | 211 | PF00498 | 0.481 |
LIG_FHA_2 | 6 | 12 | PF00498 | 0.405 |
LIG_LIR_Gen_1 | 147 | 158 | PF02991 | 0.319 |
LIG_LIR_Gen_1 | 25 | 36 | PF02991 | 0.361 |
LIG_LIR_Gen_1 | 64 | 74 | PF02991 | 0.405 |
LIG_LIR_Nem_3 | 144 | 149 | PF02991 | 0.323 |
LIG_LIR_Nem_3 | 151 | 156 | PF02991 | 0.371 |
LIG_LIR_Nem_3 | 234 | 240 | PF02991 | 0.386 |
LIG_LIR_Nem_3 | 25 | 31 | PF02991 | 0.361 |
LIG_LIR_Nem_3 | 41 | 46 | PF02991 | 0.361 |
LIG_LIR_Nem_3 | 64 | 70 | PF02991 | 0.361 |
LIG_MLH1_MIPbox_1 | 133 | 137 | PF16413 | 0.269 |
LIG_Pex14_2 | 149 | 153 | PF04695 | 0.368 |
LIG_Pex14_2 | 42 | 46 | PF04695 | 0.390 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.269 |
LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.361 |
LIG_SUMO_SIM_anti_2 | 231 | 237 | PF11976 | 0.448 |
LIG_WRC_WIRS_1 | 23 | 28 | PF05994 | 0.387 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.345 |
MOD_CK2_1 | 160 | 166 | PF00069 | 0.573 |
MOD_CK2_1 | 172 | 178 | PF00069 | 0.590 |
MOD_CK2_1 | 204 | 210 | PF00069 | 0.483 |
MOD_GlcNHglycan | 162 | 165 | PF01048 | 0.605 |
MOD_GlcNHglycan | 212 | 215 | PF01048 | 0.645 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.329 |
MOD_GSK3_1 | 124 | 131 | PF00069 | 0.348 |
MOD_GSK3_1 | 137 | 144 | PF00069 | 0.384 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.282 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.356 |
MOD_N-GLC_1 | 131 | 136 | PF02516 | 0.269 |
MOD_N-GLC_1 | 231 | 236 | PF02516 | 0.427 |
MOD_NEK2_1 | 109 | 114 | PF00069 | 0.361 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.360 |
MOD_NEK2_1 | 31 | 36 | PF00069 | 0.269 |
MOD_NEK2_1 | 5 | 10 | PF00069 | 0.309 |
MOD_NEK2_2 | 62 | 67 | PF00069 | 0.269 |
MOD_PIKK_1 | 131 | 137 | PF00454 | 0.270 |
MOD_PKA_2 | 116 | 122 | PF00069 | 0.456 |
MOD_PKA_2 | 228 | 234 | PF00069 | 0.385 |
MOD_Plk_1 | 131 | 137 | PF00069 | 0.269 |
MOD_Plk_1 | 231 | 237 | PF00069 | 0.505 |
MOD_Plk_4 | 231 | 237 | PF00069 | 0.395 |
MOD_Plk_4 | 38 | 44 | PF00069 | 0.358 |
MOD_Plk_4 | 62 | 68 | PF00069 | 0.282 |
MOD_ProDKin_1 | 138 | 144 | PF00069 | 0.409 |
MOD_SUMO_rev_2 | 213 | 221 | PF00179 | 0.602 |
TRG_ENDOCYTIC_2 | 150 | 153 | PF00928 | 0.381 |
TRG_ENDOCYTIC_2 | 237 | 240 | PF00928 | 0.387 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.403 |
TRG_ER_diArg_1 | 100 | 102 | PF00400 | 0.133 |
TRG_ER_diArg_1 | 227 | 230 | PF00400 | 0.439 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HUZ6 | Leptomonas seymouri | 64% | 100% |
A0A0S4KDV3 | Bodo saltans | 43% | 100% |
A0A1X0P6P3 | Trypanosomatidae | 43% | 100% |
A0A3Q8IIG9 | Leishmania donovani | 30% | 70% |
A0A422NR67 | Trypanosoma rangeli | 39% | 100% |
A4HE26 | Leishmania braziliensis | 32% | 100% |
A4HN31 | Leishmania braziliensis | 81% | 100% |
A4IBQ0 | Leishmania infantum | 99% | 100% |
A4IC14 | Leishmania infantum | 30% | 70% |
C9ZYX4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
E9AFI5 | Leishmania major | 94% | 100% |
E9B6P0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
E9B705 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 70% |
O74729 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 28% | 100% |
P0C1I7 | Rhizopus delemar (strain RA 99-880 / ATCC MYA-4621 / FGSC 9543 / NRRL 43880) | 31% | 100% |
Q08752 | Homo sapiens | 28% | 67% |
Q2UGK2 | Aspergillus oryzae (strain ATCC 42149 / RIB 40) | 32% | 100% |
Q4HXF6 | Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) | 30% | 66% |
Q4PCH8 | Ustilago maydis (strain 521 / FGSC 9021) | 33% | 100% |
Q4WMB6 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 29% | 100% |
Q4WP12 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 32% | 100% |
Q5BAH7 | Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) | 30% | 100% |
Q6DGG0 | Rattus norvegicus | 29% | 67% |
Q6MWS8 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 30% | 100% |
Q8L8W5 | Arabidopsis thaliana | 30% | 100% |
Q8X166 | Aspergillus niger | 32% | 100% |
Q9C566 | Arabidopsis thaliana | 30% | 68% |
Q9CR16 | Mus musculus | 29% | 67% |
Q9V3G3 | Drosophila melanogaster | 33% | 82% |
V5BTK6 | Trypanosoma cruzi | 40% | 100% |